Obesity is an independent determinant of ischemia-modified albumin 1

Obesity Facts

Volumn 5, Issue 5, 2012, Pages 700-709

  Mehmetoǧlu, Idris ^a   Kurban, Sevil ^a   Yerlikaya, Fatma Hümeyra ^a   Polat, Hakki ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

High sensitivity C reactive protein; Ischemia modified albumin; Obesity; Total antioxidant status; Total oxidant status

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INSULIN; ISCHEMIA MODIFIED ALBUMIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHEMICAL PARAMETERS; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; WAIST CIRCUMFERENCE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; LIPID METABOLISM; MALE; MYOCARDIAL ISCHEMIA; OBESITY; OXIDATIVE STRESS; RISK FACTORS; SERUM ALBUMIN; THINNESS; WAIST CIRCUMFERENCE;

EID: 84867897219     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000343954     Document Type: Article

References (32)

1. WHO Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, 3-5 June 1997. WHO Technical Report Series number 894, WHO, Geneva, 2000.
2. Haslam DW, James WP: Obesity. Lancet 2005; 366: 1197-1209. (Pubitemid 41393598)
3. Antuna-uente B, Feve B, Fellahi S, Bastard JP: Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008; 34: 2-11.
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 2003; 348: 1625-1638. (Pubitemid 36459468)
5. Higdon JV, Frei B: Obesity and oxidative stress. A direct link to CVD? Arterioscler Thromb Vasc Biol 2003; 23: 365-367. (Pubitemid 36337206)
6. Chan B, Dodsworth N, Woodrow J, Tucker A, Harris R: Site-specific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995; 227: 524-528.
7. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF: Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 2006; 92: 113-114. (Pubitemid 43021873)
8. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV: Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006; 152: 253-262. (Pubitemid 44093396)
9. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19: 311-315.
10. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC: Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010; 95: 586-591.
11. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR: Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009; 42: 666-671.
12. Piwowar A, Knapik-Kordecka M, Warwas M: Ischemia-modified albumin level in type 2 diabetes mellitus-reliminary report. Dis Markers 2008; 24: 311-317.
13. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285. (Pubitemid 38314881)
14. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
15. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP, Tonello R, Garcia SC, Moresco RN: Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem 2011; 44: 345-347.
16. Kazanis K, Dalamaga M, Kassi E, Nounopoulos C, Manolis AS, Merantzi G, Jullien G, Dionyssiou-Asteriou A: Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress. Maturitas 2011; 70: 182-187.
17. Victor RG, Kaplan NM. Systemic hypertension: mechanisms and diagnosis; in Zipes DP, Libby P, Bonow RO, Braunwald E (eds): Braunwald's Heart Disease, ed 8. Philadelphia, Elsevier Saunders, 2008, pp 1789-1806.
18. Hermsdorff HH, Puchau B, Volp AC, Barbosa KB, Bressan J, Zulet MÁ, Martínez JA: Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. Nutr Metab (Lond) 2011; 8: 59.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
20. Hermsdorff HH, Zulet MA, Puchau B, Martínez JA: Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 2011; 34: 161-170.
21. Stuart Wood I, de Heredia FP, Wang B, Trayhurn P: Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009; 68: 370-377.
22. Tamakoshi K, Yatsuya H, Kondo T, Ishikawa M, Zhang H, Murata C, Otsuka R, Mabuchi T, Hori Y, Zhu S, Yoshida T, Toyoshima H: Long-term body weight variability is associated with elevated C-reactive protein independent of current body mass index among Japanese men. Int J Obes Relat Metab Disord 2003; 27: 1059-1065. (Pubitemid 37059611)
23. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
24. Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V: Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008; 49: 260-266.
25. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-1415. (Pubitemid 32977855)
26. Santos AC, Lopes C, Guimarães JT, Barros H: Central obesity as a major determinant of increased highsensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond) 2005; 29: 1452-1456. (Pubitemid 41622224)
27. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF Jr, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O'Donnell CJ, Benjamin EJ, Fox CS: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116: 1234-1241. (Pubitemid 47517534)
28. Ahmadi N, Eshaghian S, Huizenga R, Sosnin K, Ebrahimi R, Siegel R: Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. Am J Med 2011; 124: 978-982.
29. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ: Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-439. (Pubitemid 36337219)
30. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L: Factors associated with oxidative stress in human populations. Am J Epidemiol 2002; 156: 274-285. (Pubitemid 34810481)
31. Kazanis K, Dalamaga M, Nounopoulos C, Manolis AS, Sakellaris N, Jullien G, Dionyssiou-Asteriou A: Ischemia modified albumin, high-sensitivity C-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta 2009; 408: 65-69.
32. Hartwich J, Góralska J, Siedlecka D, Gruca A, Trzos M, Dembinska-Kiec A: Effect of supplementation with vitamin E and C on plasma hsCRP level and cobalt-albumin binding score as markers of plasma oxidative stress in obesity. Genes Nutr 2007; 2: 151-154.